Compounds
US5153210A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Dec 13, 1989 |
| Grant date | Oct 6, 1992 |
| Priority date | — |
| Expiry date | Dec 13, 2009 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D309/40
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A compound of the general formula (I): ##STR1## or a pharmaceutically acceptable ester thereof; or a pharmaceutically acceptable salt thereof, wherein, PA1 R.sup.o represents a substituted or unsubstituted aryl group or a substituted or unsubstituted benzofuranyl group, PA1 X represents a bond or --O--CH.sub.2 --, PA1 R.sup.1 represents a hydrogen atom or a moiety ##STR2## wherein R.sup.o and X are as defined above; R.sup.2 and R.sup.3 independently represent a hydrogen atom or an alkyl group, PA1 n represents an integer 1 or 2, PA1 Y represents a bond or a moiety --CH.sub.2 --O--, moiety A represents an aryl group, PA1 R.sup.4 represents a linking group, and PA1 R.sup.5 represents a substituted or unsubstituted, monocyclic or fused ring heterocyclic group, having up to four heteroatoms in each ring selected from, oxygen, nitrogen and sulphur; provided that R.sup.5 is not N-piperazinyl, N-piperadinyl, N-homopiperadinyl, N-pyrrolidinyl or N-morpholinyl; pharmaceutical compositions containing such compounds and their use in medicine and agriculture.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.